QSAR and k-Nearest Neighbor Classification Analysis of Selective Cyclooxygenase-2 Inhibitors Using Topologically-Based Numerical Descriptors
暂无分享,去创建一个
[1] R. Fletcher,et al. A New Approach to Variable Metric Algorithms , 1970, Comput. J..
[2] C. G. Broyden. The Convergence of a Class of Double-rank Minimization Algorithms 2. The New Algorithm , 1970 .
[3] D. Shanno. Conditioning of Quasi-Newton Methods for Function Minimization , 1970 .
[4] D. Goldfarb. A family of variable-metric methods derived by variational means , 1970 .
[5] Milan Randic,et al. Search for all self-avoiding paths graphs for molecular graphs , 1979, Comput. Chem..
[6] L. Kier. Distinguishing Atom Differences in a Molecular Graph Shape Index , 1986 .
[7] L. Kier. Shape Indexes of Orders One and Three from Molecular Graphs , 1986 .
[8] D. Manallack,et al. Statistics using neural networks: chance effects. , 1993, Journal of medicinal chemistry.
[9] Jon W. Ball,et al. Quantitative structure‐activity relationships for toxicity of phenols using regression analysis and computational neural networks , 1994 .
[10] Matthew D. Wessel,et al. Prediction of Reduced Ion Mobility Constants from Structural Information Using Multiple Linear Regression Analysis and Computational Neural Networks , 1994 .
[11] Brian T. Luke,et al. Evolutionary Programming Applied to the Development of Quantitative Structure-Activity Relationships and Quantitative Structure-Property Relationships , 1994, J. Chem. Inf. Comput. Sci..
[12] Peter C. Jurs,et al. Automated Descriptor Selection for Quantitative Structure-Activity Relationships Using Generalized Simulated Annealing , 1995, J. Chem. Inf. Comput. Sci..
[13] J. Gierse,et al. Expression and selective inhibition of the constitutive and inducible forms of human cyclo-oxygenase. , 1995, The Biochemical journal.
[14] C. Koboldt,et al. 1,2‐Diarylcyclopentenes as Selective Cyclooxygenase‐2 Inhibitors and Orally Active anti‐Inflammatory Agents. , 1996 .
[15] P. Isakson,et al. The discovery and function of COX-2. , 1997, The Journal of rheumatology. Supplement.
[16] R. Kumar,et al. Diarylspiro[2.4]heptenes (I) as Selective Cyclooxygenase-2 Inhibitors: A Quantitative Structure—Activity Relationship Analysis. , 1998 .
[17] R. S. Rogers,et al. Synthesis and biological evaluation of the 1,5-diarylpyrazole class of cyclooxygenase-2 inhibitors: identification of 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze nesulfonamide (SC-58635, celecoxib). , 1997, Journal of medicinal chemistry.
[18] C. Koboldt,et al. 1,2-Diarylimidazoles as potent, cyclooxygenase-2 selective, and orally active antiinflammatory agents. , 1997, Journal of medicinal chemistry.
[19] Lemont B. Kier,et al. The E-State as an Extended Free Valence , 1997, J. Chem. Inf. Comput. Sci..
[20] C. Koboldt,et al. 1,2‐Diarylpyrroles as Potent and Selective Inhibitors of Cyclooxygenase‐2. , 1997 .
[21] D. Heijde. The continuing challenge of predictive factors in rheumatoid arthritis: prediction or association? , 1997 .
[22] R. Kumar,et al. Novel inhibitors of cyclooxygenase-2: the sulfones and sulfonamides of 1,2-diaryl-4,5-difluorobenzene. Analysis of quantitative structure-activity relationship. , 1998, Journal of enzyme inhibition.
[23] Zhiliang Li,et al. Approach to Estimation and Prediction for Normal Boiling Point (NBP) of Alkanes Based on a Novel Molecular Distance-Edge (MDE) Vector , 1998, J. Chem. Inf. Comput. Sci..
[24] Peter C. Jurs,et al. Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..
[25] C. Venturini,et al. Non-steroidal anti-inflammatory drug-induced renal failure: a brief review of the role of cyclo-oxygenase isoforms. , 1998, Current opinion in nephrology and hypertension.
[26] Steven L. Dixon,et al. Investigation of classification methods for the prediction of activity in diverse chemical libraries , 1999, J. Comput. Aided Mol. Des..
[27] R. Kumar,et al. 1,2-Diarylimidazoles as inhibitors of cyclooxygenase-2: a quantitative structure-activity relationship study. , 1999, Journal of enzyme inhibition.
[28] J. Gálvez,et al. Molecular search of new active drugs against Toxoplasma gondii. , 1999, SAR and QSAR in environmental research.
[29] P. Jurs,et al. Prediction of fathead minnow acute toxicity of organic compounds from molecular structure. , 1999, Chemical research in toxicology.
[30] D. Gilroy,et al. Inducible cyclooxygenase may have anti-inflammatory properties , 1999, Nature Medicine.
[31] V. Zoete,et al. Molecular orbital theory applied to the study of nonsteroidal anti-inflammatory drug efficiency. , 1999, Free radical biology & medicine.
[32] D. E. Nichols,et al. Quantitative structure-activity relationship modeling of dopamine D(1) antagonists using comparative molecular field analysis, genetic algorithms-partial least-squares, and K nearest neighbor methods. , 1999, Journal of medicinal chemistry.
[33] M. Percival,et al. The discovery of rofecoxib, [MK 966, Vioxx, 4-(4'-methylsulfonylphenyl)-3-phenyl-2(5H)-furanone], an orally active cyclooxygenase-2-inhibitor. , 1999, Bioorganic & medicinal chemistry letters.
[34] A. K. Madan,et al. Superpendentic Index: A Novel Topological Descriptor for Predicting Biological Activity , 1999, J. Chem. Inf. Comput. Sci..
[35] J. Jaén-Oltra,et al. Artificial neural network applied to prediction of fluorquinolone antibacterial activity by topological methods. , 2000, Journal of medicinal chemistry.
[36] Kenneth K Wang,et al. The "aspirin" of the new millennium: cyclooxygenase-2 inhibitors. , 2000, Mayo Clinic proceedings.
[37] D. Lesieur,et al. Comparative Molecular Field Analysis of Selective Cyclooxygenase‐2 (COX‐2) Inhibitors , 2000 .
[38] C. Koboldt,et al. Selective cyclooxygenase-2 inhibitors: heteroaryl modified 1,2-diarylimidazoles are potent, orally active antiinflammatory agents. , 2000, Journal of medicinal chemistry.
[39] D. Hadjipavlou-Litina. Quantitative structure--activity relationship (QSAR) studies on non steroidal anti-inflammatory drugs (NSAIDs). , 2000, Current medicinal chemistry.
[40] P. Jurs,et al. Classification of multidrug-resistance reversal agents using structure-based descriptors and linear discriminant analysis. , 2000, Journal of medicinal chemistry.
[41] Peter C. Jurs,et al. Prediction of IC50 Values for ACAT Inhibitors from Molecular Structure , 2000, J. Chem. Inf. Comput. Sci..
[42] D. M. van der Heijde,et al. Rofecoxib, a New Cyclooxygenase 2 Inhibitor, Shows Sustained Efficacy, Comparable With Other Nonsteroidal Anti-inflammatory Drugs A 6-Week and a 1-Year Trial in Patients With Osteoarthritis , 2000 .
[43] P. McGettigan,et al. Current problems with non-specific COX inhibitors. , 2000, Current pharmaceutical design.
[44] G. Desiraju,et al. Three-Dimensional Quantitative Structural Activity Relationship (3D-QSAR) Studies of Some 1,5-Diarylpyrazoles: Analogue Based Design of Selective Cyclooxygenase-2 Inhibitors , 2000 .
[45] P. Jurs,et al. Prediction of IC50 Values for ACAT Inhibitors from Molecular Structure. , 2000 .
[46] G. Desiraju,et al. Three-Dimensional Quantitative Structural Activity Relationship ( 3 D-QSAR ) Studies of Some 1 , 5-Diarylpyrazoles : Analogue Based Design of Selective Cyclooxygenase-2 Inhibitors , 2000 .
[47] K. Giercksky,et al. Selective inhibitors of COX-2--are they safe for the stomach? , 2000, Scandinavian journal of gastroenterology.
[48] Gregory W. Kauffman,et al. Prediction of Inhibition of the Sodium Ion—Proton Antiporter by Benzoylguanidine Derivatives from Molecular Structure. , 2000 .
[49] F. Berenbaum. Selective cyclooxygenase-2 inhibitors: hope and facts. , 2000, Joint, bone, spine : revue du rhumatisme.
[50] J. Gálvez. Use of molecular topology in the selection of new cytostatic drugs , 2000 .